Latest News

  • INNOVATION

    6 Feb 2026

    AI Alliances Are Reshaping Peptide Manufacturing in America

  • MARKET TRENDS

    5 Feb 2026

    Why Peptide Drugmakers Are Betting Big on Factories

  • TECHNOLOGY

    4 Feb 2026

    Can Algorithms Outrun the Lab in Peptide Discovery?

  • PARTNERSHIPS

    3 Feb 2026

    A Peptide Merger That Reflects Biotech’s New Priorities

A New Weapon Against Implant Infections Takes Shape

Biomedical researchers examining peptide-based implant protection methods

INSIGHTS

2 Feb 2026

Peptide therapies advance into pivotal Phase 2/3 trials, pointing to a new way to prevent implant infections if results and approvals follow

Blue pill symbolizing oral peptide drug innovation.

RESEARCH

21 Jun 2025

A Needle-Free Future? This Biotech Thinks So

Sethera's tech aims to deliver peptide drugs by pill, cutting out injections and improving chronic care.

Blue smart pill symbolizing AI in drug innovation.

PARTNERSHIPS

15 Jun 2025

Can AI Crack the Code on Peptide Drugs?

TandemAI and Perpetual join forces to revolutionize peptide drug R&D, combining AI, lab automation, and expert leadership to speed bre...

Close-up of medical vials filled with injectable solution.

PARTNERSHIPS

12 Jun 2025

From Weekly to Monthly: Lilly’s Bold Injection Shift

Partnership with Sweden’s Camurus aims to reduce injection frequency and strengthen Lilly’s metabolic health portfolio

ProteinQure logo displayed in laboratory setting.

INVESTMENT

6 Jun 2025

AI Startup Secures $11M to Supercharge Cancer Drug Discovery

ProteinQure lands $11M to accelerate AI-designed peptide drugs, targeting cancer, brain, and kidney treatments with speed and precision.

FDA headquarters sign with agency logo.

REGULATORY

16 May 2025

New FDA Rules Are Reshaping the Peptide Industry

Upcoming policy change pushes peptide sector toward stricter compliance and formal drug approval pathways

Merck headquarters exterior with company logo.

MARKET TRENDS

22 Apr 2025

Merck’s $493M Pill Bet Aims to Replace Injections

Merck and Cyprumed sign licensing deal to turn injectables into pills, highlighting a shift toward easier, patient-friendly drug formats.

SUBSCRIBE FOR UPDATES

By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.